Regenerative medicine developer Biostage scraps Nasdaq uplisting, offering

[ad_1] jittawit.21/iStock via Getty Images Regenerative medicine developer Biostage (OTC:BSTG) has scrapped plans for an uplisting and accompanying public offering. Biostage said in an SEC filing that it was withdrawing its S-1 application. The company had originally filed for the offering in June 2022. It later indicated in a November filing that it was looking … Read more

Adtech platform developer NYIAX narrows price range for proposed $8M IPO

[ad_1] 2d illustrations and photos/iStock via Getty Images NYIAX (NYX), which has developed an adtech platform with Nasdaq technology, has narrowed its price range for a proposed $8M initial public offering. NYIAX said it is now looking to raise $8M by offering 1.64M shares priced between $4.50 and $5.50. Underwriters would be granted a 30-day … Read more